Page 6 - Biologics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biologics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biologics Inc Today - Breaking & Trending Today

ADMA Biologics (NASDAQ:ADMA) Reaches New 52-Week High at $6.80

ADMA Biologics, Inc. (NASDAQ:ADMA – Get Free Report) shares reached a new 52-week high on Friday . The company traded as high as $6.80 and last traded at $6.70, with a volume of 708040 shares. The stock had previously closed at $6.74. Analyst Ratings Changes A number of equities research analysts recently weighed in on […] ....

United States , Capital Partners , Qube Research Technologies Ltd , Adma Biologics Inc , American Century Companies Inc , Sg Americas Securities , Biologics Company Profile , Cantor Fitzgerald , Biologics Inc , Securities Exchange Commission , Get Free Report , Director Steve Elms , Exchange Commission , Technologies Ltd , Century Companies , Investment Management , Adma Biologics , Nasdaq Adma ,

ADMA Biologics (ADMA) Set to Announce Quarterly Earnings on Thursday

ADMA Biologics (NASDAQ:ADMA – Get Free Report) will release its earnings data after the market closes on Thursday, May 9th. Analysts expect ADMA Biologics to post earnings of $0.05 per share for the quarter. ADMA Biologics has set its FY 2024 guidance at EPS and its FY 2025 guidance at EPS. ADMA Biologics (NASDAQ:ADMA – […] ....

United States , Biologics Inc , Securities Exchange Commission , Cantor Fitzgerald , Get Free Report , Director Steve Elms , Exchange Commission , Adma Biologics , Nasdaq Adma ,

Short Interest in ADMA Biologics, Inc. (NASDAQ:ADMA) Increases By 11.2%

ADMA Biologics, Inc. (NASDAQ:ADMA – Get Free Report) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 8,110,000 shares, an increase of 11.2% from the March 31st total of 7,290,000 shares. Based on an average daily trading volume, of 2,530,000 shares, the short-interest […] ....

United States , United Kingdom , Dekabank Deutsche Girozentrale , Commonwealth Equity Services , Adma Biologics Inc , Biologics Inc , Stephens Consulting , Cambridge Investment Research Advisors Inc , Cantor Fitzgerald , Biologics Company Profile , Sawgrass Asset Management , Get Free Report , Director Steve Elms , Investment Research Advisors , Asset Management , Bank Deutsche Girozentrale , Equity Services , Adma Biologics , Nasdaq Adma ,

Bristol-Myers Q1 Loss Narrower Than Expected, Sales Beat - ADMA Biologics (NASDAQ:ADMA), ANI Pharmaceuticals (NASDAQ:ANIP)

Bristol-Myers Squibb Company (NYSE: BMY) reported an adjusted loss per share of $4.40, narrower than the Zacks Consensus Estimate of a loss of $4.53 per share. In the year-ago quarter, BMY posted adjusted earnings per share of $2.05. ....

United States , Bristol Myers , Bristol Myers Squibb Company , Pharmaceuticals Inc , Bristol Myers Squibb , Bristol Myers Squibb Company Price , Karuna Therapeutics Inc , Biologics Inc , Rayzebio Inc , European Union , Zacks Consensus Estimate , Legacy Portfolio , Myers Squibb Company Price , Myers Squibb Company , Mirati Therapeutics , Karuna Therapeutics , Zacks Rank , Strong Buy ,

Theriva™ Biologics to Present Preclinical Data Supporting the Potential Synergy of VCN-01 and First-Line Pancreatic Cancer Chemotherapy Regimens at the American Society for Cell and Gene Therapy 27th Annual Meeting

– Lead product candidate, VCN-01 in combination with liposomal irinotecan demonstrated enhanced anti-tumor effects in a human pancreatic mouse xenograft– – The observed synergy emphasizes. ....

United States , Sheila Connelly , Theriva Biologics , Stevena Shallcross , Chris Calabrese , Lifesci Advisors , Biologics Inc , Company Annual Report On Form , Globenewswire Inc , American Society For Cell , Theriva Biologics Inc , Gene Therapy , Annual Meeting , Chief Executive Officer , Enhanced Anti Tumor Efficacy , Combination Therapy , Oncolytic Adenovirus , Liposomal Irinotecan , Human Pancreatic Mouse , Vice President , Session Date , Theriva Biologic , Private Securities Litigation Reform Act , Annual Report , Sci Advisors ,